🇺🇸 FDA
Pipeline program

The pivotal bioequivalence study comparing the test product to the reference product, which belongs to the group of medicines used in treatment of schizophrenia in adult patients.

1028/25

Phase 1 other active

Quick answer

The pivotal bioequivalence study comparing the test product to the reference product, which belongs to the group of medicines used in treatment of schizophrenia in adult patients. for Not applicable (submitted trial is a BE study in healthy subjects). is a Phase 1 program (other) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Lacuna Pharma Pty Ltd
Indication
Not applicable (submitted trial is a BE study in healthy subjects).
Phase
Phase 1
Modality
other
Status
active

Clinical trials